Week of January 10, 2023 | Vol. 12, Issue 1

Below are summaries and charts with the past week's transactions from the different healthcare sectors. For a detailed table showing data for each industry transaction click on any of the charts. Total transaction values are provided in USD millions.

Pharma Services Sector Snapshot 1H 2022

August 2022

Market Insight Capital Markets Update

October 2022

M&A PIPELINE

Representative Current Retained Sell-Side And Partnering Opportunities

Project Beach

Pharma Services | Sell-Side

Acquisition opportunity of Clinical Trial Services Provider

Project Elevate

Pharma Services | Capital Raise

Digital health patient adherence platform

Project Ester

Consumer Health | Strategic Partnering 

Partnering opportunity for launch and commercialization of novel OTC dry eye product

Project Gateway

Pharma | Sell-Side

Acquisition opportunity of US specialty generics platform and small portfolio

Project Jazz

Pharma Services | Sell-Side

Acquisition opportunity of US compounding pharmacy and pharmacy services provider

Project Panther

Pharma Services | Sell-Side

Acquisition opportunity of US OTC CDMO

Project Power Play

Pharma | Buy-Side

Seeking established brands across all therapeutic categories or growth assets in Neurology / CNS

Project Trident

Pharma | Buy-Side

Seeking generic liquids or established brands across all formats sold through the hospital / institutional channel

FEATURED HEADLINES

A Sampling of Industry Headlines

Oregon health agency approves Amazon, One Medical acquisition, moving $3.9B deal one step forward

Fierce Healthcare - Jan 3, 2023

GE HealthCare completes spinout into 'more focused, more agile' standalone company

Fierce Biotech - Jan 4, 2023

Delpharm Acquires Leiden Development Center from Dr. Reddy's

Contract Pharma - Jan 4, 2023

Bruker expands CRO business with Biognosys majority ownership deal

Fierce Biotech - Jan 4, 2023

Aurisco to Build Oligonucleotides Manufacturing Facility in China

Contract Pharma - Jan 5, 2023

Clinscience's owner takes majority stake in Florida-based CRO OncoBay

Fierce Biotech - Jan 5, 2023

Sarepta and Catalent Expand Manufacturing Partnership

Contract Pharma - Jan 5, 2023

IQVIA tapped by Biostage to run its first clinical trial of esophageal implant

Fierce Biotech - Jan 5, 2023

TANNER NEWS

The Mexican Pharma Market

Global pharma companies are turning their focus to Mexico, with its low manufacturing costs and proximity to the US as two of the major advantages. We take a look at some of the factors behind the growth of and challenges within this market. Read more.

Tanner EOY Celebrations

2022 was a great year of growth and change that was advanced by our amazing team and the ongoing support of our incredible partners and friends. We look forward to continuing to enhance access to medicine with the help of all those that make up the Tanner Family. Thank you!

Let's Connect!

The Tanner team will be attending several networking events in the coming weeks. Let’s connect to discuss how our organizations can improve patient lives, together.